MAPT and Alzheimer disease: In summary, our present study indicates that AS-IV could suppress tau hyperphosphorylation, synaptic deficits, neuroinflammation, and pyroptosis to prevent AD-like phenotypes, likely through interactions of PPARγ with caspase-1, GSK3Β, PSEN1, and TRPV1.